av608
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2006 (NCT00294346)
Timeline
Indications
Mechanism of action
- Neurokinin 1 receptorANTAGONIST
TACR1 antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- av608
- av608
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00335660 | Phase 2 | Jun 1, 2006 | Avera Pharmaceuticals, University of London |
| NCT00316550 | Phase 1 | Apr 1, 2006 | Avera Pharmaceuticals, University of California, Los Angeles |
| NCT00294346 | Phase 2 | Feb 1, 2006 | Avera Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Avera Pharmaceuticals | For profit | 3 | 3 | 2 | 2006 |
| University of California, Los Angeles | Academic/Hospital | 1 | 0 | 1 | 2006 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2006 |
3 organizations
Page 1 / 1